INTERIM ANALYSIS OF A PHASE-III STUDY ON PREOPERATIVE RADIATION-THERAPY IN RESECTABLE RECTAL-CARCINOMA - TRIAL OF THE GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-ON-TREATMENT-OF-CANCER (EORTC)

被引：0
|
作者：
GERARD, A
BERROD, JL
PENE, F
LOYGUE, J
LAUGIER, A
BRUCKNER, R
CAMELOT, G
ARNAUD, JP
METZGER, U
BUYSE, M
DALESIO, O
DUEZ, N
机构：
[1] HOP ST ANTOINE, F-75571 PARIS 12, FRANCE
[2] HOP TENON, F-75970 PARIS 20, FRANCE
[3] UNIV MAINZ KLINIKEN, MAINZ, FED REP GER
[4] UNIV HOSP BESANCON, BESANCON, FRANCE
[5] CTR MED CHIRURG, STRASBOURG, FRANCE
[6] UNIV HOSP ZURICH, CH-8091 ZURICH, SWITZERLAND
[7] EUROPEAN ORG RES TREATMENT CANC DATA CTR, BRUSSELS, BELGIUM
来源：
CANCER | 1985年 / 55卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19850515)55:10<2373::AID-CNCR2820551012>3.0.CO;2-D
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2373 / 2379
页数：7
相关论文
共 42 条
  • [21] CARDIOVASCULAR SIDE-EFFECTS OF DIETHYLSTILBESTROL, CYPROTERONE-ACETATE, MEDROXYPROGESTERONE ACETATE AND ESTRAMUSTINE PHOSPHATE USED FOR THE TREATMENT OF ADVANCED PROSTATIC-CANCER - RESULTS FROM EUROPEAN ORGANIZATION FOR RESEARCH ON TREATMENT OF CANCER TRIAL-30761 AND TRIAL-30762 - COMPARISON OF DIETHYLSTILBESTROL, CYPROTERONE-ACETATE AND MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF ADVANCED PROSTATIC-CANCER - FINAL ANALYSIS OF RANDOMIZED PHASE-III TRIAL OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-ON-TREATMENT-OF-CANCER UROLOGICAL GROUPT
    DEVOOGT, HJ
    PAVONEMACALUSO, M
    SYLVESTER, R
    SCHRODER, FH
    JOURNAL OF UROLOGY, 1988, 140 (06): : 1557 - 1557
  • [22] MITOMYCIN-C VERSUS ESTRAMUSTINE IN THE TREATMENT OF HORMONE-RESISTANT METASTATIC PROSTATE-CANCER - THE FINAL ANALYSIS OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GENITOURINARY GROUP PROSPECTIVE RANDOMIZED PHASE-III STUDY-(30865)
    NEWLING, DWW
    FOSSA, SD
    TUNN, UW
    KURTH, KH
    DEPAUW, M
    SYLVESTER, R
    JOURNAL OF UROLOGY, 1993, 150 (06): : 1840 - 1844
  • [23] Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
    Postmus, PE
    Haaxma-Reiche, H
    Smit, EF
    Groen, HJM
    Karnicka, H
    Lewinski, T
    van Meerbeeck, J
    Clerico, M
    Gregor, A
    Curran, D
    Sahmoud, T
    Kirkpatrick, A
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3400 - 3408
  • [24] THE FINAL ANALYSIS OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP PHASE-III CLINICAL-TRIAL (PROTOCOL-30805) COMPARING ORCHIECTOMY, ORCHIECTOMY PLUS CYPROTERONE-ACETATE AND LOW-DOSE STILBESTROL IN THE MANAGEMENT OF METASTATIC CARCINOMA OF THE PROSTATE
    ROBINSON, MRG
    SMITH, PH
    RICHARDS, B
    NEWLING, DWW
    DEPAUW, M
    SYLVESTER, R
    EUROPEAN UROLOGY, 1995, 28 (04) : 273 - 283
  • [25] Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy:: A phase III study of the European Organization for Research and Treatment of Cancer Genitourinary Group
    Fosså, SD
    Slee, PHT
    Brausi, M
    Horenblas, S
    Hall, RR
    Hetherington, JW
    Aaronson, N
    de Prijck, L
    Collette, L
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 62 - 71
  • [26] Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975
    Smit, EF
    van Meerbeeck, JPAM
    Lianes, P
    Debruyne, C
    Legrand, C
    Schramel, F
    Smit, H
    Gaafar, R
    Biesma, B
    Manegold, C
    Neymark, N
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) : 3909 - 3917
  • [27] Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma:: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
    Aass, N
    De Mulder, PHM
    Mickisch, GHJ
    Mulders, P
    van Oosterom, AT
    van Poppel, H
    Fossa, SD
    de Prijck, L
    Sylvester, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4172 - 4178
  • [28] RANDOMIZED PHASE-II STUDY OF A COMBINATION OF CISPLATIN (DDP), 5-FLUOROURACIL (5-FU), AND ALLOPURINOL (HPP) VERSUS 5-FU IN ADVANCED COLORECTAL-CARCINOMA - AN EORTC GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP-STUDY
    BLEIBERG, H
    VANDERLINDEN, B
    BUYSE, M
    HAEGELE, P
    PAILLOT, B
    TAGNON, A
    WILS, J
    CARTEI, G
    FORNASIERO, A
    DUEZ, N
    CANCER INVESTIGATION, 1990, 8 (05) : 471 - 475
  • [29] ON THE VALUE OF INTENSIVE REMISSION-INDUCTION CHEMOTHERAPY IN ELDERLY PATIENTS OF 65+ YEARS WITH ACUTE MYELOID-LEUKEMIA - A RANDOMIZED PHASE-III STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LEUKEMIA GROUP
    LOWENBERG, B
    ZITTOUN, R
    KERKHOFS, H
    JEHN, U
    ABELS, J
    DEBUSSCHER, L
    CAUCHIE, C
    PEETERMANS, M
    SOLBU, G
    SUCIU, S
    STRYCKMANS, P
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) : 1268 - 1274
  • [30] Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)
    Van Zandwijk, N
    Smit, EF
    Kramer, GWP
    Schramel, F
    Gans, S
    Festen, J
    Termeer, A
    Schlosser, NJJ
    Debruyne, C
    Curran, D
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2658 - 2664
12345